TIMP-Antigen

N/A

Report date: 2025/11/28 11:20:46

Base Information

Drug NameTIMP-Antigen
Drug Alias NameTIMP-multiple-linked myelin peptide (Cour Pharmaceutical)TIMP-Antigen tolerizing immune modifying nanoparticles (Cour Pharmaceutical)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCour Pharmaceutical Development Company Inc
China Registration ClassN/A

Develop Information

Active CompaniesCour Pharmaceutical Development Company Inc
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A